1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Kidney conditions
  5. Chronic kidney disease

Pegcetacoplan for treating primary complement 3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis in people 12 years and over [ID6489]

Awaiting development [GID-TA11633] Expected publication date: TBC

  • Project information
  • Project documents

24302-Pegcetacoplan-for-C3-Glomerulopathy-or-Immune-Complex-Membranoproliferative-Glomerulonephritis-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)